Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006
Arterial Injuries in Transsphenoidal Surgery for Pituitary Adenoma:The Role of Angiography and Endovascular Treatment
ANJR 18:655-665, Raymond,J.,et al, 1997
Risk of Second Brain Tumour after Conservative Surgery and Radiotherapy for Pituitary Adenoma
BMJ 304:1343-1346, Brada,M.,et al, 1992
Isolated Oculomotor Nerve Palsy due to Pituitary Apoplexy Missed on CT scan
Neurol 94:e1774-e1777, Marzoughi, S.,et al, 2020
A 45-year-old Woman with Right Limb Weakness
Neurol 88:e103-e107, Li, S.,et al, 2017
Acute Headache Diagnosis in Pregnant Women
Neurol 85:1024-1030, Robbins, M.S.,et al, 2015
Clinical Reasoning: A 42-year-old Man with Severe Headache, Fever, and Acute Coma
Neurol 82:e9-e13, Han, F.,et, 2014
Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010
Cavernous Sinus Syndrome: A Series of 126 Patients
Medicine 86:278-281, Fern�ndez,S.,et al, 2007
Prolactinoma
NEJM 349:2035-2041, Schlechte,J.A., 2003
Pituitary Carcinoma as a Cause of Acromegaly
NEJM 345:1645-1646, LeRoux,C.W.,et al, 2001
Long-term Treatment of Acromegaly With Pegvisomant, a Growth Hormone Receptor Antagonist
Lancet 358:1754-1759,1743, van der Lely,A.J.,et al, 2001
Pituitary Surgery for Acromegaly, Should be Done by Specialists
BMJ 319:588-589, Clayton,R.N.,et al, 1999
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing's Disease
NEJM 336:172-177, 2151997., Estrada,J.,et al, 1997
Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997
Complications of Transsphenoidal Surgery:Results of a National Survey, Review of the Literature, and Personal Experience
Neurosurg 40:225-236, Ciric,I.,et al, 1997
Cavernous Sinus Syndrome
Arch Neurol 53:967-971, Keane,J.R., 1996
Hypopituitarism
NEJM 330:1651-1662, Vance,M.L., 1994
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Octreotide Therapy for Thyroid-Stimulation Hormone-Secreting Pituitary Adenomas, A Follow-up of 52 Patients
Ann Int Med 119:236-240, Chanson,P.,et al, 1993
Relapse of Hyperprolactinemia Revisited
NEJM 329:1357, Serri,O.,et al, 1993
Prolactin-Secreting Macroadenomas in Adolescents, Response to Bromocriptine Therapy
Am J Dis Child 147:1057-1061, Tyson,D.,et al, 1993
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
Delayed Radiation Necrosis of the CNS in Patients Irradiated for Pituitary Tumours
JNNP 55:949-955, Grattan-Smith,P.J.,et al, 1992
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Brain Tumors
NEJM 324:1471-1476, 1555-15641991., Black,P.McL., 1991
Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
The'Incidentaloma'of the Pituitary Gland is Neurosurgery Required
JAMA 263:2772-2776, Reincke,M.,et al, 1990
Acromegaly in an Infant
Pediatrics 83:998-1002, Blumberg,D.L.,et al, 1989
Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988
Pituitary Apoplexy
BMJ 297:1526-1527, Lewin,I.G.,et al, 1988
Brain Tumors in Pregnancy
Semin Neurol 8:214-221, Simon,R.H., 1988
Treatment of Pituitary Adenomas
NEJM 317:45-46, Kohler,P.O., 1987
Giant Invasive Prolactinomas
Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987
Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin Analogue
NEJM 317:12-17, Comi,R.J.,et al, 1987
Visual Improvement with SMS 201-995 in a Patient with a Thyrotropin-Secreting Pituitary Adenoma
NEJM 317:53-54, Guillaussea,P.J.,et al, 1987
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985
Rapid Size Reduction of Giant Prolactinoma Following Medical Treatment
J Comput Assist Tomogr 8:131-133, Perani,D.,et al, 1984
Treatment of Prolactinomas with Megavoltage Radiotherapy
BMJ 288:1105-1109, Grossman,A.,et al, 1984
Long-Term Follow-Up of Transphenoidal Selective Adenomectomy for Prolactinoma
JAMA 252:921-924, Rodman,E.F.,et al, 1984
Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984
Failure of Bromocriptine to Maintain Reduction in Size of a Macroprolactinoma
BMJ 287:451-452, Breidahl,H.D.,et al, 1983
Pergolide for the Treatment of Pituitary Tumors Secreting Prolactin or Growth Hormone
NEJM 309:704-709, Kleinberg,D.K.,et al, 1983
Reduction in Size of Prolactin-secreting Tumours in Men Treated with Pergolide
BMJ 285:465-467, Kendall-Taylor,P.,et al, 1982
Regression of Pituitary Prolactinoma With Bromocriptine Administration
JAMA 245:1149-1150, Velentzas,C.,et al, 1981
Prolactinoma:A Question of Rational Treatment
BMJ 283:1561-1562, Edwards,C.R.W.,et al, 1981
Management of Hormone-Secreting Pituitary Adenomas
NEJM 302:210-214, Zervas,N.T.,et al, 1980